-
Je něco špatně v tomto záznamu ?
Establishing the Optimal Time for Induction of Labor in Women with Diet-Controlled Gestational Diabetes Mellitus: A Single-Center Observational Study
P. Šimják, H. Krejčí, M. Hornová, M. Mráz, A. Pařízek, M. Kršek, M. Haluzík, K. Anderlová
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2019-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Health & Medicine (ProQuest)
od 2019-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
36362638
DOI
10.3390/jcm11216410
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
To determine the optimal week for labor induction in women with diet-controlled gestational diabetes mellitus by comparing differences in perinatal and neonatal outcomes of labor induction to expectant management at different gestational weeks. Methods: This was a retrospective analysis of a prospectively recruited cohort of 797 singleton pregnancies complicated by diet-controlled gestational diabetes mellitus that were diagnosed, treated, and delivered after 37 weeks in a tertiary, university-affiliated perinatal center between January 2016 and December 2021. Results: The incidence of neonatal complications was highest when delivery occurred at 37 weeks, whereas fetal macrosomia occurred mostly at 41 weeks (20.7%); the frequency of large for gestational age infants did not differ between the groups. Conversely, the best neonatal outcomes were observed at 40 weeks due to the lowest number of neonates requiring phototherapy for neonatal jaundice (1.7%) and the smallest proportion of neonates experiencing composite adverse neonatal outcomes defined as neonatal hypoglycemia, phototherapy, clavicle fracture, or umbilical artery pH < 7.15 (10.4%). Compared with expectant management, the risk for neonatal hypoglycemia was increased for induction at 39 weeks (adjusted odds ratio 12.29, 95% confidence interval 1.35-111.75, p = 0.026) and that for fetal macrosomia was decreased for induction at 40 weeks (adjusted odds ratio 0.11, 95% confidence interval 0.01-0.92, p = 0.041), after adjusting for maternal pre-pregnancy body mass index, nulliparity, and mean pregnancy A1c. Conclusions: The lowest rate of neonatal complications was observed at 40 weeks. Labor induction at 40 weeks prevented fetal macrosomia.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22031410
- 003
- CZ-PrNML
- 005
- 20230127131149.0
- 007
- ta
- 008
- 230119s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/jcm11216410 $2 doi
- 035 __
- $a (PubMed)36362638
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Šimják, Patrik $u Department of Gynecology and Obstetrics, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic $1 https://orcid.org/0000000308112085
- 245 10
- $a Establishing the Optimal Time for Induction of Labor in Women with Diet-Controlled Gestational Diabetes Mellitus: A Single-Center Observational Study / $c P. Šimják, H. Krejčí, M. Hornová, M. Mráz, A. Pařízek, M. Kršek, M. Haluzík, K. Anderlová
- 520 9_
- $a To determine the optimal week for labor induction in women with diet-controlled gestational diabetes mellitus by comparing differences in perinatal and neonatal outcomes of labor induction to expectant management at different gestational weeks. Methods: This was a retrospective analysis of a prospectively recruited cohort of 797 singleton pregnancies complicated by diet-controlled gestational diabetes mellitus that were diagnosed, treated, and delivered after 37 weeks in a tertiary, university-affiliated perinatal center between January 2016 and December 2021. Results: The incidence of neonatal complications was highest when delivery occurred at 37 weeks, whereas fetal macrosomia occurred mostly at 41 weeks (20.7%); the frequency of large for gestational age infants did not differ between the groups. Conversely, the best neonatal outcomes were observed at 40 weeks due to the lowest number of neonates requiring phototherapy for neonatal jaundice (1.7%) and the smallest proportion of neonates experiencing composite adverse neonatal outcomes defined as neonatal hypoglycemia, phototherapy, clavicle fracture, or umbilical artery pH < 7.15 (10.4%). Compared with expectant management, the risk for neonatal hypoglycemia was increased for induction at 39 weeks (adjusted odds ratio 12.29, 95% confidence interval 1.35-111.75, p = 0.026) and that for fetal macrosomia was decreased for induction at 40 weeks (adjusted odds ratio 0.11, 95% confidence interval 0.01-0.92, p = 0.041), after adjusting for maternal pre-pregnancy body mass index, nulliparity, and mean pregnancy A1c. Conclusions: The lowest rate of neonatal complications was observed at 40 weeks. Labor induction at 40 weeks prevented fetal macrosomia.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Krejčí, Hana $u Department of Gynecology and Obstetrics, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic $u 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Hornová, Markéta $u Department of Gynecology and Obstetrics, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Mráz, Miloš $u Diabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic
- 700 1_
- $a Pařízek, Antonín $u Department of Gynecology and Obstetrics, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Kršek, Michal $u 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Haluzík, Martin $u Diabetes Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic
- 700 1_
- $a Anderlová, Kateřina $u Department of Gynecology and Obstetrics, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic $u 3rd Department of Medicine, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, 128 08 Prague, Czech Republic
- 773 0_
- $w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 11, č. 21 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36362638 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230119 $b ABA008
- 991 __
- $a 20230127131140 $b ABA008
- 999 __
- $a ok $b bmc $g 1889489 $s 1182743
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2022 $b 11 $c 21 $e 20221029 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
- LZP __
- $a Pubmed-20230119